Gene-modified T cells aid kidney patients
Researchers successfully genetically modified T cells to reduce the production of antibodies that cause rejection of transplanted organs, leading to successful kidney transplants for three patients with severe allergies. The results showed a decrease in harmful antibody levels, representing an important step toward enabling kidney failure patients with "hyperreactivity" to receive compatible organ transplants.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading